Vertex Pharmaceuticals (VRTX)

Income Before Tax

$1.39B

Quarterly · Period ending: · USD

VRTX logo

VRTX Income Before Tax

Latest reported$1.39B
VRTX Quarterly Pre-Tax Income ($0.00 → $1.39B)
High-resolution chart · PNG

VRTX income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
1,392,200,000
1,252,900,000
1,331,000,000
1,298,800,000
1,283,000,000
730,400,000
1,136,500,000
1,224,100,000
-3,391,200,000
1,279,100,000
1,147,600,000
1,179,200,000
1,161,500,000
891,500,000
1,076,800,000
1,176,400,000
1,024,400,000
954,800,000
870,900,000
1,082,741,000
-44,200,000
820,960,000
888,623,000
745,871,000
824,770,000
657,534,000
676,950,000
70,666,000
327,138,000
320,165,000
32,497,000
136,511,000
216,591,000
214,642,000
112,442,000
-417,170,000
35,506,000
253,533,000
20,306,000
-42,034,000
-18,021,000
-30,617,000
-77,829,000
-92,486,000
-190,861,000
-198,405,000
-178,594,000
-166,577,000
-158,689,000
-231,654,000
-340,253,000
-129,406,000
-63,511,000
-442,940,000
-80,772,000
-5,112,000
-14,405,000
87,908,000
210,801,000
200,610,000
-174,870,000
-176,096,000
-170,972,000
-208,957,000
-200,006,000
-165,271,000
-642,178,000
-149,565,000
-171,297,000
-162,672,000
-143,504,000
-130,044,000
-91,321,000
-96,154,000
-92,024,000
-107,033,000
-117,767,000
-80,728,000
-206,891,000
-51,802,000
-77,658,000
-50,087,000
165,286,000
-79,578,000
-40,988,000
-44,720,000
-35,472,000
-38,771,000
-44,269,000
-40,438,000
111,607,000
-86,421,000
-89,928,000
20,611,000
33,452,000
-33,452,000
0
0
-19,524,000
-29,229,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.